27 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
net sales milestone payments. Joint steering committees have been formed to oversee the clinical studies, regulatory filings, manufacturing … payments. Joint steering committees have been formed to oversee the clinical studies, regulatory filings, manufacturing, and commercial readiness
8-K
EX-1.1
v7w15
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
S-3
EX-1.2
hkntf c72grmaknyy
1 Jul 22
Shelf registration
4:13pm
DEF 14A
m4zylmkl iuqw78a62k
28 Apr 22
Definitive proxy
8:36am
424B3
fnxlbjlnh8dm 409z
12 Nov 21
Prospectus supplement
8:41am
424B3
nl4aalei
13 Aug 21
Prospectus supplement
5:25pm
S-4/A
EX-10.13
hfxretmbl wu
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.8
5qnc q5f4470t7o5
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.9
dwisls
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.12
68fhaaf7ih
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.7
mp0yqmp007psb3lzakks
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.15
ckh 9jh6n
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.14
3fh xhccms
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm